NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
What the buyer wrote
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS Englan…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Work starts
- 1 Feb 2026
- Work ends
- 30 Sep 2027
- Where
- in London, in the North East, in the North West, in the East Midlands, in the West Midlands, in the East of England, in the South East, in the South West
- Kind of work
- Pharmacy and medicines
Who the buyer named
Julian Farley - Procurement Manager was the named contact on this notice. Questions closed on 24 Oct 2025, 13:00 BST.